Database : MEDLINE
Search on : Maxillary and Sinus and Neoplasms [Words]
References found : 4123 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 413 go to page                         

  1 / 4123 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 29443742
[Au] Autor:Qin Y; Lu Y; Zheng L; Liu H
[Ad] Address:Cancer Center.
[Ti] Title:Ghost cell odontogenic carcinoma with suspected cholesterol granuloma of the maxillary sinus in a patient treated with combined modality therapy: A case report and the review of literature.
[So] Source:Medicine (Baltimore);97(7):e9816, 2018 Feb.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: Ghost cell odontogenic carcinoma (GCOC) is a rare malignant odontogenic tumor with aggressive growth characteristics. PATIENT CONCERNS: A 41-year-old Chinese male visited our hospital in 2013, with a 4-month history of bloody purulent rhinorrhea with a peculiar smell in the right nasal cavity. DIAGNOSES: The patient suffered from recurrent GCOC with suspected cholesterol granuloma of the maxillary sinus. The patient was incorrectly diagnosed with a calcifying epithelial odontogenic tumor at his first recurrence. Physical examination, radiological examination, and histopathology were used to identify GCOC. INTERVENTIONS: Considering the recurrence of GCOC and poor effects of single surgery, postoperative adjuvant chemotherapy and concurrent chemoradiotherapy were performed after radical surgical excision. OUTCOMES: So far, no significant evidence has suggested recurrence or metastasis after a long-term follow-up. LESSONS: We advocate wide surgery with clean margins at the first accurate diagnosis. Combined modality therapy could be taken for the recurrent GCOC. We expect to provide a new treatment strategy to prevent the growth of this neoplasm.
[Mh] MeSH terms primary: Carcinoma/therapy
Cholesterol
Granuloma, Foreign-Body/therapy
Neoplasm Recurrence, Local/therapy
Odontogenic Tumors/therapy
Paranasal Sinus Diseases/therapy
[Mh] MeSH terms secundary: Adult
Carcinoma/complications
Carcinoma/pathology
Chemoradiotherapy
Chemotherapy, Adjuvant
Combined Modality Therapy/methods
Diagnostic Errors
Granuloma, Foreign-Body/etiology
Granuloma, Foreign-Body/pathology
Humans
Male
Maxillary Sinus/pathology
Maxillary Sinus/surgery
Neoplasm Recurrence, Local/complications
Neoplasm Recurrence, Local/pathology
Odontogenic Tumors/complications
Odontogenic Tumors/pathology
Paranasal Sinus Diseases/etiology
Paranasal Sinus Diseases/pathology
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:97C5T2UQ7J (Cholesterol)
[Em] Entry month:1802
[Cu] Class update date: 180222
[Lr] Last revision date:180222
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180215
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009816

  2 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29373783
[Au] Autor:Lam HP; Addicks BL; Farmer RW; Fancy T
[Ti] Title:Metastatic Renal Cell Carcinoma of the Head and Neck: A Case Series.
[So] Source:W V Med J;113(2):48-51, 2017 Mar-Apr.
[Is] ISSN:0043-3284
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Background: Renal cell carcinoma (RCC) accounts for over 80% of malignant tumors arising from the kidney. However, metastatic RCC to the head and neck is a relatively rare entity. Case Presentation: We describe three patients with metastatic RCC to the head and neck with the involvement of the parapharyngeal space, the level V region of the neck, and the maxillary sinus. Conclusion: Metastatic RCC in the head and neck is uncommon; however, it must be taken into consideration given a patient with a history of RCC. Multiple pathways allow for the spread of RCC to the head and neck region. Treatment options include mastectomy or local radiation and systemic chemotherapy.
[Mh] MeSH terms primary: Carcinoma, Renal Cell/diagnostic imaging
Carcinoma, Renal Cell/secondary
Head and Neck Neoplasms/diagnostic imaging
Head and Neck Neoplasms/secondary
Kidney Neoplasms/pathology
[Mh] MeSH terms secundary: Aged
Aged, 80 and over
Female
Humans
Maxillary Sinus Neoplasms/secondary
Time Factors
Tomography, X-Ray Computed
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180215
[Lr] Last revision date:180215
[Js] Journal subset:IM
[Da] Date of entry for processing:180127
[St] Status:MEDLINE

  3 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Dedivitis, Rogerio Aparecido
Full text

[PMID]: 28468168
[Au] Autor:Salmen FS; Oliveira MR; Navarro CM; Dedivitis RA; Pereira Filho VA; Gabrielli MFR
[Ad] Address:*Araraquara Dental School, São Paulo State University (UNESP) †São Paulo School of Medicine, University of São Paulo (USP), Santos, Brazil.
[Ti] Title:Aggressive Osteoblastoma in the Maxilla: Unusual Lesion in the Craniofacial Skeleton.
[So] Source:J Craniofac Surg;28(3):794-797, 2017 May.
[Is] ISSN:1536-3732
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Osteoblastomas are benign bone tumors, which are unusual in the craniofacial skeleton, being most often observed in the axial skeleton and long bones. The most common site in the maxillofacial region is the mandible and the involvement of the maxilla and paranasal sinuses is extremely rare. Although it is a benign lesion, the aggressive variant raises concerns due to its huge local destructive potential and tendency to relapse. In this clinical case, an aggressive osteoblastoma is described in a 7-year-old patient. The lesion was large and fully involved the left maxilla, including the maxillary sinus and the nasal cavity. Recurrent volume increase was observed 2 months following enucleation of the lesion and en bloc resection of the maxillary segment was performed. Histological and immunohistochemical evaluation associated with clinical and imaging findings allowed to define the tumor as an aggressive variant of osteoblastoma and not osteosarcoma, despite the aggressive behavior. The patient recovered well and no relapses were observed after 12 months following maxillary resection.
[Mh] MeSH terms primary: Bone Neoplasms/surgery
Maxilla/pathology
Maxillary Neoplasms/diagnosis
Neoplasm Staging
Oral Surgical Procedures/methods
Osteoblastoma/diagnosis
[Mh] MeSH terms secundary: Bone Neoplasms/diagnosis
Child
Humans
Magnetic Resonance Imaging
Male
Maxilla/surgery
Maxillary Neoplasms/surgery
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180209
[Lr] Last revision date:180209
[Js] Journal subset:D
[Da] Date of entry for processing:170505
[St] Status:MEDLINE
[do] DOI:10.1097/SCS.0000000000003641

  4 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28468156
[Au] Autor:Arslan HH; Tasli H; Cebeci S; Gerek M
[Ad] Address:*Department of Otolaryngology, Head and Neck Surgery, Gulhane Military Medical School †Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
[Ti] Title:The Management of the Paranasal Sinus Osteomas.
[So] Source:J Craniofac Surg;28(3):741-745, 2017 May.
[Is] ISSN:1536-3732
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVE: Osteoma is the most common benign tumor of the paranasal sinuses. The clinical characteristics and treatment of this disease remain controversial. The aim of this study is to determine the appropriate method of treatment approach according to the features of osteomas. METHODS: Forty-one patients with paranasal sinus osteomas were included in the study. According to the location and the size of tumors, patients were followed up or operated. Surgical treatment was performed via external, endoscopic, or combined approaches for symptomatic patients. Routine physical and radiological evaluations were performed for follow-up in asymptomatic patients. RESULTS: Paranasal sinus osteomas were found most common in frontal sinus (n = 26, 63.4%) followed by ethmoid sinus (n = 10, 24.3%), maxillary sinus (n = 4, 9.7%), and sphenoid sinus (n = 1, 2.4%). Of the patients with frontal sinus osteomas, the endoscopic approach was performed in 11 patients, external approach (osteoplastic flap) in 9, and combined (external + endoscopic) approach in 5 patients. Endoscopic approach was preferred in all patients with ethmoid osteoma. The combination of Caldwell-Luc procedure and endoscopic approach was performed in 1 patient with maxillary sinus osteoma. In 3 patients, who underwent osteoplastic flap technique, mucocele developed in the postoperative period. Partial loss of vision developed postoperatively in 1 patient with a giant ethmoid osteoma. There were no other complications and recurrence in an average of 29 months follow-up. CONCLUSION: Paranasal sinus osteomas are rare, slow-growing benign lesions, with potentially serious complications. Main treatment option for sphenoid and ethmoid sinus and other symptomatic osteomas are surgical resection. Radiographic follow-up is necessary for asymptomatic lesions. Selection of surgical resection method depends on tumor location and size. Patients should be observed for recurrence with periodic examination and imaging techniques. Follow-up should be performed at least in 1-year intervals after the surgery. LEVEL OF EVIDENCE: 1c.
[Mh] MeSH terms primary: Endoscopy/methods
Ethmoid Sinus
Frontal Sinus
Maxillary Sinus
Osteoma/surgery
Paranasal Sinus Neoplasms/surgery
Reconstructive Surgical Procedures/methods
[Mh] MeSH terms secundary: Adult
Aged
Female
Humans
Male
Middle Aged
Osteoma/diagnosis
Paranasal Sinus Neoplasms/diagnosis
Postoperative Period
Tomography, X-Ray Computed
Treatment Outcome
Young Adult
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180209
[Lr] Last revision date:180209
[Js] Journal subset:D
[Da] Date of entry for processing:170505
[St] Status:MEDLINE
[do] DOI:10.1097/SCS.0000000000003397

  5 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29322795
[Au] Autor:Laco J; Kovarikova H; Chmelarova M; Vosmikova H; Sieglova K; Bubancova I; Dundr P; Nemejcova K; Michalek J; Celakovsky P; Mottl R; Sirak I; Vosmik M; Marek I; Geryk T; Mejzlik J; Satankova J; Ryska A
[Ti] Title:Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study.
[So] Source:Neoplasma;65(1):113-123, 2018.
[Is] ISSN:0028-2685
[Cp] Country of publication:Slovakia
[La] Language:eng
[Ab] Abstract:The aim of this study was a detailed clinicopathological investigation of sinonasal NUT midline carcinoma (NMC), including analysis of DNA methylation and microRNA (miRNA) expression. Three (5%) cases of NMC were detected among 56 sinonasal carcinomas using immunohistochemical screening and confirmed by fluorescence in situ hybridization. The series comprised 2 males and 1 female, aged 46, 60, and 65 years. Two tumors arose in the nasal cavity and one in the maxillary sinus. The neoplasms were staged pT1, pT3, and pT4a (all cN0M0). All patients were treated by radical resection with adjuvant radiotherapy. Two patients died 3 and 8 months after operation, but one patient (pT1 stage; R0 resection) experienced no evidence of disease at 108 months. Microscopically, all tumors consisted of infiltrating nests of polygonal cells with vesicular nuclei, prominent nucleoli and basophilic cytoplasm. Abrupt keratinization was present in only one case. Immunohistochemically, there was a diffuse expression of cytokeratin (CK) cocktail, CK7, p40, p63, and SMARCB1/INI1. All NMCs tested negative for EBV and HPV infection. Two NMCs showed methylation of RASSF1 gene. All other genes (APC, ATM, BRCA1, BRCA2, CADM1, CASP8, CD44, CDH13, CDKN1B, CDKN2A, CDKN2B, CHFR, DAPK1, ESR1, FHIT, GSTP1, HIC1, KLLN, MLH1a, MLH1b, RARB, TIMP3, and VHL) were unmethylated. All NMCs showed upregulation of miR-9 and downregulation of miR-99a and miR-145 and two cases featured also upregulation of miR-21, miR-143, and miR-484. In summary, we described three cases of sinonasal NMCs with novel findings on DNA methylation and miRNA expression, which might be important for new therapeutic strategies in the future.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1801
[Cu] Class update date: 180111
[Lr] Last revision date:180111
[St] Status:In-Data-Review
[do] DOI:10.4149/neo_2018_161122N581

  6 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 27860481
[Au] Autor:Jordáková J
[Ti] Title:Porucha motility bulbu s diplopií jako první príznak tumoru prorustajícího do orbity z vedlejsích dutin nosních. [Ocular Motility Disorders with Diplopia Like the first Symptoms of Paranasal Tumours with Orbital Invasion - a Case Report].
[So] Source:Cesk Slov Oftalmol;72(4):157-163, 2016.
[Is] ISSN:1211-9059
[Cp] Country of publication:Czech Republic
[La] Language:cze
[Ab] Abstract:Presentation of two case reports about our experiences with diagnostics of paranasal tumours in patients with diplopia or ocular motility disorders which were the first symptoms of these tumours. Furthermore, the following diagnostic and therapeutic procedure which has been conducted in cooperation with other hospital departments is presented. The first case report is an example of primary paranasal tumour, the second case report represents secondary infiltration of maxillary sinus and orbital invasion. METHODS: A case reports.Key words: diplopia, paranasal tumours, orbital invasion, spinocellulary carcinoma.
[Mh] MeSH terms primary: Carcinoma, Squamous Cell/diagnosis
Diplopia/diagnosis
Ocular Motility Disorders/diagnosis
Orbital Neoplasms/diagnosis
Paranasal Sinus Neoplasms/diagnosis
[Mh] MeSH terms secundary: Aged
Eye Evisceration
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Invasiveness
Tomography, X-Ray Computed
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1711
[Cu] Class update date: 171128
[Lr] Last revision date:171128
[Js] Journal subset:IM
[Da] Date of entry for processing:161119
[St] Status:MEDLINE

  7 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28756096
[Au] Autor:Hanazawa T; Yamasaki K; Chazono H; Okamoto Y
[Ad] Address:Department of Otorhinolaryngology/Head and Neck Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba City, Chiba 260-8670, Japan. Electronic address: thanazawa@faculty.chiba-u.jp.
[Ti] Title:Endoscopic contralateral transmaxillary approach for pterygoid process osteotomy in total maxillectomy: A technical case report.
[So] Source:Auris Nasus Larynx;, 2017 Jul 26.
[Is] ISSN:1879-1476
[Cp] Country of publication:Netherlands
[La] Language:eng
[Ab] Abstract:An approach for total maxillectomy with endoscopic transection of the pterygoid process via the contralateral maxillary sinus is described. In total maxillectomy, the resection of the pterygoid process of the sphenoid is a key step for successful resection. However, a conventional craniofacial approach requires extensive incision in the face, elevation of the lateral cheek flap. Even after elevation of the lateral cheek flap, visualization of this region is not good. An endoscopic approach through the contralateral maxillary sinus improved visualization of the pterygoid process, and osteotomy using a diamond-drilling bar was successfully performed. This technique has the potential to widen the indication for total maxillectomy in malignant neoplasms of the maxillary sinus.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1707
[Cu] Class update date: 170730
[Lr] Last revision date:170730
[St] Status:Publisher

  8 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28734993
[Au] Autor:Vass G; Bella Z; Tóbiás Z; Nagy A; Iván L; Rovó L
[Ad] Address:Assistant Lecturer, Department of Otorhinolaryngology, Head and Neck Surgery, University of Szeged, Szeged, Hungary. Electronic address: vassgabor@hotmail.com.
[Ti] Title:Esthetically Favorable Surgical Alternative for the Removal of Sinonasal Malignant Tumors-The Modified Facial Degloving Technique.
[So] Source:J Oral Maxillofac Surg;75(10):2272.e1-2272.e10, 2017 Oct.
[Is] ISSN:1531-5053
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:PURPOSE: The widely used external approach (Weber-Fergusson incision) for the removal of maxillary ethmoid tumors leaves stigmatizing scars and deformities on the patient's face. As an alternative technique, the scarless facial degloving approach was first described in the 1970s; since then, several modifications have been developed. PATIENTS AND METHODS: The authors have been using a modified facial degloving technique for 7 years to remove maxillary ethmoid tumors. This article is a retrospective methodologic review. The inclusion criteria for this retrospective study were patients who underwent the modified facial degloving technique for management of malignant maxillary ethmoid tumors. The exclusion criteria were patients who did not undergo a surgical procedure (who received primary chemoradiation therapy) and patients who underwent an endoscopic surgical procedure for an early-stage localized tumor. The authors describe their method, which provides for a wide surgical approach using an osteoplastic flap for the entire nasal and paranasal region, with good cosmetic results. They present the adaptability of their method for 3 malignant maxillary ethmoid tumors in different locations. RESULTS: From 2012 through 2016, 23 consecutive patients underwent surgery with the modified facial degloving approach at the Department of Otorhinolaryngology, Head and Neck Surgery at the University of Szeged (Szeged, Hungary). The authors evaluated their results with acoustic rhinometry and photographic documentation of postoperative facial expressions. Neither narrowing of the nasal cavity on the operated side (loss of nasal breathing function) nor facial movement dysfunction was visible in these patients. CONCLUSION: Although several modifications of the original facial degloving approach have been published, in the present technique, the novel osteoplastic flap and the intact soft tissue of the nasal and midfacial region result in shorter hospitalization time and fewer complications. No functional or esthetic distortion was visible. No severe complications were observed; the patients' only complaint was the dryness of the nasal mucosa and temporary crusting of the nose. The present modified facial degloving technique offers proper and safe surgical resection for tumors of the maxillary ethmoid region. It can be routinely combined with endoscopic techniques and, if necessary, can be converted to an open approach.
[Mh] MeSH terms primary: Ethmoid Bone
Maxillary Neoplasms/surgery
Paranasal Sinus Neoplasms/surgery
Reconstructive Surgical Procedures/methods
Skull Neoplasms/surgery
[Mh] MeSH terms secundary: Adult
Aged
Esthetics
Female
Humans
Male
Middle Aged
Retrospective Studies
Young Adult
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Entry month:1710
[Cu] Class update date: 171012
[Lr] Last revision date:171012
[Js] Journal subset:AIM; D; IM
[Da] Date of entry for processing:170724
[St] Status:MEDLINE

  9 / 4123 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28674562
[Au] Autor:Chehal A; Lobo R; Naim A; Azinovic I
[Ad] Address:Centre Régional d'oncologie Al Hoceima, Maroc.
[Ti] Title:Améloblastome du sinus maxillaire traité par radiothérapie. [Ameloblastoma of the maxillary sinus treated with radiation therapy].
[So] Source:Pan Afr Med J;26:169, 2017.
[Is] ISSN:1937-8688
[Cp] Country of publication:Uganda
[La] Language:fre
[Ab] Abstract:Ameloblastoma is a benign aggressive odontogenic tumor which requires early diagnosis and appropriate treatment. It commonly affects the mandible and radical surgery is the gold standard treatment. We report the case of a patient with ameloblastoma in extremely advanced phase affecting the maxillary sinus who was treated with intensity modulated conformal radiation therapy. Patient's evolution was marked by complete remission maintained after 24 months follow-up. Maxillary ameloblastoma is not well documented in the literature. It is usually diagnosed at the later stage when optimal surgery cannot be performed. This case study aimed to demonstrate that radiation therapy is a real therapeutic alternative in the treatment of advanced and inoperable forms of ameloblastoma.
[Mh] MeSH terms primary: Ameloblastoma/radiotherapy
Maxillary Neoplasms/radiotherapy
Maxillary Sinus/pathology
[Mh] MeSH terms secundary: Aged
Ameloblastoma/pathology
Follow-Up Studies
Humans
Male
Maxillary Neoplasms/pathology
Remission Induction
Treatment Outcome
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1707
[Cu] Class update date: 170717
[Lr] Last revision date:170717
[Js] Journal subset:IM
[Da] Date of entry for processing:170705
[St] Status:MEDLINE
[do] DOI:10.11604/pamj.2017.26.169.8992

  10 / 4123 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 28493366
[Au] Autor:Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
[Ad] Address:Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[Ti] Title:Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
[So] Source:J Pathol;242(4):400-408, 2017 Aug.
[Is] ISSN:1096-9896
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:Sinonasal undifferentiated carcinoma (SNUC) is a high-grade malignancy with limited treatment options and poor outcome. A morphological spectrum of 47 sinonasal tumours including 17 (36.2%) SNUCs was analysed at genomic level. Thirty carcinomas (cohort 1) were subjected to a hybridization exon-capture next-generation sequencing assay (MSK-IMPACT ) to interrogate somatic variants in 279 or 410 cancer-related genes. Seventeen sinonasal tumours (cohort 2) were examined only for the presence of IDH1/2 exon 4 mutations by Sanger sequencing. IDH2 R172 single nucleotide variants were overall detected in 14 (82.4%) SNUCs, in two (20%) poorly-differentiated carcinomas with glandular/acinar differentiation, and in one of two high-grade neuroendocrine carcinomas, large cell type (HGNECs). No IDH2 mutation was detected in any of five olfactory neuroblastomas or in any of five SMARCB1-deficient carcinomas. Among 12 IDH2-mutated cases in cohort 1, five (41.7%) harboured co-existing TP53 mutations, four (33.3%) CDKN2A/2B loss-of-function alterations, four (33.3%) MYC amplification, and three (25%) had concurrent SETD2 mutations. AKT1 E17K and KIT D816V hotspot variants were each detected in one IDH2-mutated SNUC. The vast majority of SNUCs and variable proportions of other poorly-differentiated sinonasal carcinomas may be amenable to IDH2-targeted therapy. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
[Mh] MeSH terms primary: Carcinoma/genetics
Isocitrate Dehydrogenase/genetics
Maxillary Sinus Neoplasms/genetics
Mutation
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Biomarkers, Tumor/genetics
Carcinoma/pathology
Carcinoma, Neuroendocrine/genetics
Carcinoma, Small Cell/genetics
DNA Mutational Analysis/methods
Female
Gene Deletion
Genes, p53/genetics
High-Throughput Nucleotide Sequencing/methods
Humans
Male
Maxillary Sinus Neoplasms/pathology
Middle Aged
SMARCB1 Protein/deficiency
SMARCB1 Protein/genetics
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Biomarkers, Tumor); 0 (SMARCB1 Protein); 0 (SMARCB1 protein, human); EC 1.1.1.41 (Isocitrate Dehydrogenase); EC 1.1.1.41 (isocitrate dehydrogenase 2, human)
[Em] Entry month:1709
[Cu] Class update date: 171015
[Lr] Last revision date:171015
[Js] Journal subset:IM
[Da] Date of entry for processing:170512
[St] Status:MEDLINE
[do] DOI:10.1002/path.4915


page 1 of 413 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information